CGAS and metabolic dysfunction-associated steatotic liver disease: The crosstalk between mammalian target of rapamycin complex 1 (mTORC1) signaling pathway and the cGAS–STING signaling pathway in mammals reveals the important role of this signaling axis in NAFLD (Luo et al., 2018).